ESTIMATED
05/15/2024
05/15/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$1.17 | -$1.17 | -$1.17 |
Q2 2024 | 1 | -$0.77 | -$0.77 | -$0.77 |
Q3 2024 | 0 | -$0.72 | -$0.72 | -$0.72 |
Q4 2024 | 0 | $0.25 | $0.25 | $0.25 |
Q1 2025 | 0 | -$0.06 | -$0.06 | -$0.06 |
Q2 2025 | 0 | -$0.15 | -$0.15 | -$0.15 |
Q3 2025 | 0 | -$0.15 | -$0.15 | -$0.15 |
Q4 2025 | 0 | $0.08 | $0.08 | $0.08 |
Biofrontera Inc. last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-1.85 earnings per share for the quarter, missing analysts' consensus estimates of $-1.63 by $0.22. The company had revenue of 7.90 M for the quarter and had revenue of 34.07 M for the year. Biofrontera Inc. has generated $-13 earnings per share over the last year ($-13.02 diluted earnings per share) and currently has a price-to-earnings ratio of -0.13. Biofrontera Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, August 11th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/15/2024 | Q1 2024 | -$1.63 | -$2.88 | -1.25 | $10.86 M | $7.90 M | 03/15/2024 | Q4 2023 | -$1.19 | $1.65 | 2.84 | $11.52 M | $10.60 M | 11/09/2023 | Q3 2023 | -$4.23 | -$4.64 | -0.41 | $8.88 M | 08/11/2023 | Q2 2023 | -$5.14 | -$7.23 | -2.09 | $5.85 M | 05/12/2023 | Q1 2023 | -$4.40 | -$5.60 | -1.2 | $9.15 M | $8.73 M | 03/13/2023 | Q4 2022 | -$2.60 | -$2.09 | 0.51 | $10.35 M | $10.14 M | 11/14/2022 | Q3 2022 | -$6.40 | -$2.26 | 4.14 | $4.32 M | 08/12/2022 | Q2 2022 | -$6.20 | $7.51 | 13.71 | $4.46 M | 05/13/2022 | Q1 2022 | -$2.80 | $6.50 | 9.3 | $9.75 M | 04/08/2022 | Q4 2021 | -$25.89 | $9.24 M | $9.17 M | 11/30/2021 | Q3 2021 | -$11.60 | -$40.03 | -28.43 | $4.86 M | $4.33 M | 06/30/2021 | Q2 2021 | -$9.15 | $5.86 M | 03/31/2021 | Q1 2021 | -$8.84 | $4.74 M | 12/30/2020 | Q4 2020 | -$0.46 | $8.57 M | 09/29/2020 | Q3 2020 | $0.00 | $3.25 M |
---|
A. Biofrontera Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, August 11th, 2024 based off last year's report dates.
A. The conference call for Biofrontera Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Biofrontera Inc.'s latest earnings report can be read online.
A. Biofrontera Inc. (NASDAQ:BFRI) has a recorded annual revenue of $34.07 M.
A. Biofrontera Inc. (NASDAQ:BFRI) has a recorded net income of $34.07 M. Biofrontera Inc. has generated $-13.02 earnings per share over the last four quarters.
A. Biofrontera Inc. (NASDAQ:BFRI) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is -0.01.